UTime Limited launched a smartwatch with blood pressure monitoring, integrating health features and gaining medical certification in China.
Quiver AI Summary
UTime Limited, a technology company based in Shenzhen, China, has launched a new smartwatch featuring integrated blood pressure monitoring, enhancing its portfolio in the health technology sector. This smartwatch employs the Oscillo metric method for accurate blood pressure measurements and includes a micro air pump and high-precision pressure sensor for user convenience. It has received China NMPA Class II Medical Device Registration. Besides blood pressure monitoring, the watch offers health data such as heart rate, blood oxygen levels, sleep analysis, and various sports tracking modes. UTime's CEO, Hengcong Qiu, emphasizes the company's commitment to combining health monitoring with mobile technology to address growing health management needs.
Potential Positives
- Launch of smartwatch with integrated blood pressure monitoring showcases UTime Limited's commitment to innovation in health technology.
- Product utilizes a market-validated measurement principle, indicating reliability and credibility in health monitoring.
- The smartwatch has received China NMPA Class II Medical Device Registration, enhancing its marketability and compliance with healthcare regulations.
- Incorporation of multiple health metrics (heart rate, blood oxygen saturation, sleep analysis, sports tracking) positions the product to appeal to health-conscious consumers.
Potential Negatives
- The company's new smartwatch product may face scrutiny regarding its medical claims, particularly in the blood pressure monitoring functionality, raising concerns about regulatory compliance and the accuracy of the health data provided.
- The reliance on forward-looking statements without specific future guidance may create uncertainty among investors about the company's growth trajectory and product performance in the competitive health technology market.
- The press release does not provide detailed information on how the smartwatch's functionality compares to competitors, which could indicate potential weaknesses in the product's market positioning.
FAQ
What is the new product launched by UTime Limited?
UTime Limited launched a smartwatch featuring integrated blood pressure monitoring functionality, expanding its health technology product portfolio.
What technology does the smartwatch use for blood pressure monitoring?
The smartwatch utilizes the Oscillo metric method and integrates a micro air pump along with a high-precision pressure sensor.
Has the smartwatch received any certifications?
Yes, it has obtained the China NMPA Class II Medical Device Registration Certificate.
What additional health features does the smartwatch offer?
In addition to blood pressure monitoring, the watch provides heart rate, blood oxygen saturation, sleep analysis, and sports mode tracking.
Who is the CEO of UTime Limited?
The CEO of UTime Limited is Mr. Hengcong Qiu, who emphasized the company's focus on health monitoring integration.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
Full Release
SHENZHEN, China, Oct. 28, 2025 (GLOBE NEWSWIRE) -- UTime Limited (Nasdaq: WTO), a global technology company engaged in the design and development of mobile devices, today announced the launch of a smartwatch with integrated blood pressure monitoring functionality, further expanding its product portfolio in the health technology sector.
The product utilizes the Oscillo metric method, a market-validated measurement principle, and integrates a micro air pump and high-precision pressure sensor to provide users with a convenient blood pressure monitoring experience. It has obtained China NMPA Class II Medical Device Registration Certificate (Registration Certificate No.: Guangdong Instrument Note No. 20162070928). In addition to its core blood pressure monitoring feature, the watch also provides multi-dimensional health data references, including heart rate, blood oxygen saturation, sleep analysis, and multiple sports mode tracking. The product design balances wearing comfort with daily practicality and includes interactive features such as voice reminders.
Mr. Hengcong Qiu, Chief Executive Officer of UTime Limited, stated, "We focus on integrating practical health monitoring functions with mobile smart devices. The launch of this watch represents our efforts to meet the growing user demand for health management."
About UTime Limited
Operating under the NASDAQ ticker WTO, UTime Limited is engaged in the design, development, production, sales and brand operation of mobile devi c es in China and globally . The company aims to provide cost-effective products and serves a broad customer base.
Safe Harbor Statement
This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact are forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors that may cause the Company’s actual results, performance or achievements to be materially different from any future results, performances or achievements expressed or implied by the forward-looking statements. For additional risk factors, please review UTime Limited’s Annual Report on Form 20-F and other SEC filings. Forward-looking statements are made only as of the date of this release.The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required under applicable law.
Contact:
[email protected]
UTime Limited
7th Floor, Building 5A
Shenzhen Software Industry Base, Nanshan District
Shenzhen, People’s Republic of China 518061
Tel: (86) 755 86512266
Attachment
